Some authors suggest that the loss of CB1 receptor in mouse liver or the administration of CB1 receptor antagonists can reduce hepatic steatosis, as CB1 can be blocked by THC or CBD from cannabis (Chen and Kim 2024; Dibba et al. 2018). The gene discussed is CNR1; the disease is fatty liver disease.